Revelation Biosciences, Inc., (REVB): Price and Financial Metrics


Revelation Biosciences, Inc., (REVB): $10.35

-0.15 (-1.43%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add REVB to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

REVB Stock Price Chart Interactive Chart >

Price chart for REVB

REVB Price/Volume Stats

Current price $10.35 52-week high $100.80
Prev. close $10.50 52-week low $5.91
Day low $9.14 Volume 126,100
Day high $11.17 Avg. volume 28,116
50-day MA $7.86 Dividend yield N/A
200-day MA $16.23 Market Cap 243.60M

Revelation Biosciences, Inc., (REVB) Company Bio


Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal congestion. It also develops REVTx-200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for immunity; and REVDx-501, a rapid home use diagnostic to detect respiratory viral infection. The company was founded in 2019 and is based in New York, New York.


REVB Latest News Stream


Event/Time News Detail
Loading, please wait...

REVB Latest Social Stream


Loading social stream, please wait...

View Full REVB Social Stream

Latest REVB News From Around the Web

Below are the latest news stories about REVELATION BIOSCIENCES INC that investors may wish to consider to help them evaluate REVB as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Tuesday morning!

William White on InvestorPlace | December 13, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

We're starting off the day with an overview of the biggest pre-market stock movers traders need to know about for Friday morning!

William White on InvestorPlace | December 2, 2022

Revelation Biosciences Inc. Announces Future Clinical Development Plans Based on Recent Biomarker Analysis and Significant Reduction in New Collagen Deposition (Fibrosis) in Preclinical Model

SAN DIEGO, Calif., November 18, 2022--Revelation Biosciences Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment of disease, today announced that recently completed exploratory biomarker analysis has confirmed clinical development plans for REVTx-300 in the treatment of CKD and AKI. This new biomarker data is in addition to the previously-announced significant reduction in

Yahoo | November 18, 2022

Revelation Biosciences Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Recent Corporate Progress

SAN DIEGO, November 10, 2022--Revelation Biosciences Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a life sciences company that is focused on the development of immunologic based therapies for the prevention and treatment of disease, today reported its third quarter 2022 financial results and highlighted recent corporate progress.

Yahoo | November 10, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning!

William White on InvestorPlace | November 3, 2022

Read More 'REVB' Stories Here

REVB Price Returns

1-mo 51.26%
3-mo 21.84%
6-mo -41.52%
1-year -88.12%
3-year N/A
5-year N/A
YTD 55.56%
2022 -98.14%
2021 1.49%
2020 -74.36%
2019 37.54%
2018 1.60%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6887 seconds.